A detailed history of Walleye Capital LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 21,000 shares of TGTX stock, worth $620,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,000
Previous 72,000 70.83%
Holding current value
$620,340
Previous $1.28 Million 61.64%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $90,283 - $132,618
5,246 New
5,246 $122,000
Q1 2024

May 15, 2024

BUY
$13.02 - $21.3 $16,314 - $26,688
1,253 Added 12.83%
11,017 $167,000
Q4 2023

Feb 14, 2024

SELL
$6.68 - $18.81 $530,452 - $1.49 Million
-79,409 Reduced 89.05%
9,764 $166,000
Q3 2023

Nov 14, 2023

BUY
$8.36 - $26.5 $745,486 - $2.36 Million
89,173 New
89,173 $745,000
Q2 2022

Aug 08, 2022

BUY
$3.74 - $10.66 $741,391 - $2.11 Million
198,233 New
198,233 $842,000
Q2 2020

Aug 14, 2020

SELL
$8.9 - $21.84 $147,206 - $361,233
-16,540 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$7.14 - $15.99 $98,960 - $221,621
-13,860 Reduced 45.59%
16,540 $162,000
Q4 2019

Feb 14, 2020

BUY
$5.1 - $11.2 $155,040 - $340,480
30,400 New
30,400 $338,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.